XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash $ 6,774 $ 10,278
Trade accounts receivable, net of allowance for expected credit losses of $301 and $300, respectively 27,754 31,761
Inventories, net 43,994 42,215
Prepaid expenses and other current assets 7,908 5,949
Total current assets 86,430 90,203
Property, plant and equipment, net 20,245 21,117
Goodwill 37,792 37,571
Other intangible assets, net 14,487 15,107
Deferred income taxes, net 9,125 10,567
Other noncurrent assets 4,361 3,711
Total assets 172,440 178,276
Current liabilities:    
Accounts payable 12,681 11,336
Current portion of long-term debt 2,000 2,000
Accrued compensation and related benefits 2,631 3,115
Accrued expenses and other current liabilities 8,892 7,279
Total current liabilities 26,204 23,730
Long-term debt, net 5,888 23,624
Deferred income taxes 1,626 1,714
Other noncurrent liabilities 4,093 3,781
Total liabilities 37,811 52,849
Commitments and Contingencies  
Stockholders’ equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 21,062,627 shares at September 30, 2024 and 20,783,607 shares at December 31, 2023; outstanding – 16,626,513 shares at September 30, 2024 and 16,347,493 shares at December 31, 2023 2,106 2,078
Capital in excess of par value 191,582 189,160
Accumulated deficit (34,636) (40,754)
Accumulated other comprehensive loss (3,084) (3,660)
Treasury stock - at cost; 4,436,114 shares at September 30, 2024 and 4,436,114 shares at December 31, 2023 (21,492) (21,492)
Total Ultralife Corporation equity 134,476 125,332
Non-controlling interest 153 95
Total stockholders’ equity 134,629 125,427
Total liabilities and stockholders’ equity $ 172,440 $ 178,276